topic

914 A 47-marker immune profiling flow cytometry assay to enable automated and comprehensive antigen-specific immune analysis
Michael Cohen, Huihui Hao, Stephen Li, Lauren Tracey, Connie Inlay, Christina Loh

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1017; DOI: 10.1136/jitc-2023-SITC2023.0914
915 Lymph node colonization promotes distant tumor metastasis through the induction of tumor-specific immune tolerance
Nathan E Reticker-Flynn, Julia A Belk, Weiruo Zhang, Pamela Basto, John B Sunwoo, Sylvia K Plevritis, Ansuman T Satpathy, Edgar G Engleman

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1018; DOI: 10.1136/jitc-2023-SITC2023.0915
916 Making their own off switch: Fgl2 produced by antigen-specific CD8⁺ T cells tempers the CD8⁺ T-cell response via apoptosis of FcγRIIB⁺ CD8⁺ T cells
Kelsey B Bennion, Danya Liu, Abdelhameed Dawood, Megan M Wyatt, Mosalah S Abdel-Hakeem, Chrystal M Paulos, Mandy L Ford

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1019; DOI: 10.1136/jitc-2023-SITC2023.0916
917 A novel B7H3×4–1BB bispecific antibody for solid tumor treatment
Liansheng Cheng, Qun Zhao, Dayan Zhang

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1020; DOI: 10.1136/jitc-2023-SITC2023.0917
918 Functional heterogeneity of CD4⁺ tumor-infiltrating lymphocytes
Arianna Draghi, Christopher A Chamberlain, Shawez Khan, Katja Harbst, Mario Presti, Martin Lauss, Michael D Crowther, Agnete WP Jensen, Anne-Christine K Rasmussen, Benedetta Albieri, Torben Lorentzen, Mads H Andersen, Göran Jönsson, Inge Svane, Marco Donia

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1021; DOI: 10.1136/jitc-2023-SITC2023.0918
919 Exploring new strategies for improved ADCC responses with humanized NK cells
Yuan Fang, Hongyan Sun, Shiying Guo, Lingyu Song, Jun Wang, Jing Zhao, Xiang Gao

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1022; DOI: 10.1136/jitc-2023-SITC2023.0919
920 ETS-1 regulates the activation of human CD8 T-Cells in response to immune checkpoint inhibitors
Jacob Hirdler, Zhiming Mao, Cristina Correia, Fabrice Lucien-Matteoni, Haidong Dong

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1023; DOI: 10.1136/jitc-2023-SITC2023.0920
921 ADGRG1 cell surface expression enriches for neoantigen-reactive CD4 lymphocytes from human tumors
Kyle J Hitscherich, Sri Krishna, Steven A Rosenberg, Frank Lowery

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1024; DOI: 10.1136/jitc-2023-SITC2023.0921
922 Leveraging parenchymal antigen presentation by microglia for the control of breast cancer brain metastases
Aaron J Longworth, Timothy P McMullen, Isam Adam, Tatyana Lev, Hannah Savage, Paige Halas, Devon A Lawson

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1025; DOI: 10.1136/jitc-2023-SITC2023.0922
923 Characterization and clinical significance of the intra and inter-tumor spatial immune heterogeneity using 3-dimensional multiplexed phenotyping in non-small cell lung cancer
Miguel Lopez de Rodas, Zachary Frohock, Xiao Liu, Noelia Vilarino, Viviana Ahumada, Scott Gettinger, R Krishna Murthy Karuturi, Joshy George, Yi Li, Kurt Schalper

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1026; DOI: 10.1136/jitc-2023-SITC2023.0923

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages